Healthcare provider profile · identity verified

James T Cort, MD

Internal Medicine · EAST ORANGE, NJ · NPI 1851467294

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	1093	273
Atorvastatin Calcium	Atorvastatin Calcium	888	244
Metformin Hcl	Metformin Hcl	465	124
Albuterol Sulfate Hfa	Albuterol Sulfate	294	95
Metoprolol Succinate	Metoprolol Succinate	282	66
Gabapentin	Gabapentin	256	75
Omeprazole	Omeprazole	247	61
Olmesartan Medoxomil	Olmesartan Medoxomil	219	65
Losartan Potassium	Losartan Potassium	206	60
Januvia	Sitagliptin Phosphate	193	35
Furosemide	Furosemide	185	57
Hydrochlorothiazide	Hydrochlorothiazide	180	57
Lisinopril	Lisinopril	174	36
Simvastatin	Simvastatin	165	43
Pantoprazole Sodium	Pantoprazole Sodium	162	46
Eliquis	Apixaban	160	37
Valsartan	Valsartan	158	43
Glipizide	Glipizide	155	44
Metoprolol Tartrate	Metoprolol Tartrate	150	44
Clopidogrel	Clopidogrel Bisulfate	149	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	141	44
Levothyroxine Sodium	Levothyroxine Sodium	134	38
Azithromycin	Azithromycin	130	105
Ibuprofen	Ibuprofen	118	50
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	104	27
Zolpidem Tartrate	Zolpidem Tartrate	100	30
Prednisone	Prednisone	98	58
Tamsulosin Hcl	Tamsulosin Hcl	91	20
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	90	26
Rosuvastatin Calcium	Rosuvastatin Calcium	78	24
Carvedilol	Carvedilol	77	22
Amoxicillin	Amoxicillin	72	48
Donepezil Hcl	Donepezil Hcl	69	12
Acetaminophen-Codeine	Acetaminophen With Codeine	65	39
Fluticasone Propionate	Fluticasone Propionate	65	30
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	64	27
Naproxen	Naproxen	63	27
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	59	21
Gemfibrozil	Gemfibrozil	59	suppressed
Hydralazine Hcl	Hydralazine Hcl	58	15
Labetalol Hcl	Labetalol Hcl	57	20
Clonidine Hcl	Clonidine Hcl	56	20
Tradjenta	Linagliptin	56	suppressed
Potassium Chloride	Potassium Chloride	55	25
Pravastatin Sodium	Pravastatin Sodium	54	21
Meclizine Hcl	Meclizine Hcl	52	23
Nifedipine Er	Nifedipine	52	16
Spironolactone	Spironolactone	50	suppressed
Jardiance	Empagliflozin	49	suppressed
Latanoprost	Latanoprost	49	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	46	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	23
Enalapril Maleate	Enalapril Maleate	45	13
Levemir Flexpen	Insulin Detemir	45	13
Glimepiride	Glimepiride	44	15
Mirtazapine	Mirtazapine	44	suppressed
Benazepril Hcl	Benazepril Hcl	41	suppressed
Xarelto	Rivaroxaban	40	suppressed
Entresto	Sacubitril/Valsartan	38	suppressed
Famotidine	Famotidine	38	suppressed
Lorazepam	Lorazepam	38	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Hydrocortisone	Hydrocortisone	35	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	12
Metoclopramide Hcl	Metoclopramide Hcl	34	16
Folic Acid	Folic Acid	31	suppressed
Mometasone Furoate	Mometasone Furoate	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Repaglinide	Repaglinide	29	suppressed
Methylprednisolone	Methylprednisolone	28	20
Humalog Kwikpen U-100	Insulin Lispro	27	11
Synthroid	Levothyroxine Sodium	27	suppressed
Finasteride	Finasteride	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Ozempic	Semaglutide	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Insulin Lispro	Insulin Lispro	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Megestrol Acetate	Megestrol Acetate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Fluconazole	Fluconazole	19	12
Sertraline Hcl	Sertraline Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Cilostazol	Cilostazol	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	17	15
Verapamil Sr	Verapamil Hcl	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	16	suppressed
Levofloxacin	Levofloxacin	15	12
Prednisolone Acetate	Prednisolone Acetate	15	suppressed
Ramipril	Ramipril	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Baclofen	Baclofen	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lactulose	Lactulose	11	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error